HICKLIN; Daniel J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HICKLIN; Daniel J..The latest application filed is for "separation moieties and methods of use thereof".

Company Profile

4.7.19

HICKLIN; Daniel J. - Boston MA
Hicklin; Daniel J. - Montclair NJ
Hicklin; Daniel J. - Upper Montclair NJ
Hicklin; Daniel J. - Glen Ridge NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Separation Moieties And Methods Of Use Thereof App 20220220181 - WINSTON; William ; et al.	2022-07-14
Method Of Detecting Tim-3 Using Antibody Molecules To Tim-3 App 20220185883 - Sabatos-Peyton; Catherine Anne ; et al.	2022-06-16
Combination Therapies Comprising Antibody Molecules To Tim-3 App 20220133889 - Dranoff; Glenn ; et al.	2022-05-05
Method of detecting TIM-3 using antibody molecules to TIM-3 Grant 11,155,620 - Sabatos-Peyton , et al. October 26, 2	2021-10-26
Antibody molecules to TIM-3 and uses thereof Grant 10,981,990 - Sabatos-Peyton , et al. April 20, 2	2021-04-20
Antibody Molecules To Tim-3 And Uses Thereof App 20200308277 - Sabatos-Peyton; Catherine Anne ; et al.	2020-10-01
Antibody Molecules To Tim-3 And Uses Thereof App 20200223917 - Sabatos-Peyton; Catherine Anne ; et al.	2020-07-16
Antibody molecules to TIM-3 and uses thereof Grant 10,472,419 - Sabatos-Peyton , et al. Nov	2019-11-12
Combination Therapies Comprising Antibody Molecules To Tim-3 App 20180207273 - Dranoff; Glenn ; et al.	2018-07-26
Antibody molecules to TIM-3 and uses thereof Grant 9,884,913 - Sabatos-Peyton , et al. February 6, 2	2018-02-06
Antibody Molecules To Tim-3 And Uses Thereof App 20170198041 - Sabatos-Peyton; Catherine Anne ; et al.	2017-07-13
Antibody Molecules To Tim-3 And Uses Thereof App 20170190777 - Sabatos-Peyton; Catherine Anne ; et al.	2017-07-06
Antibody molecules to TIM-3 and uses thereof Grant 9,605,070 - Sabatos-Peyton , et al. March 28, 2	2017-03-28
Antibody Molecules To Tim-3 And Uses Thereof App 20150218274 - Sabatos-Peyton; Catherine Anne ; et al.	2015-08-06
Antibodies against vascular endothelial growth factor receptor-1 Grant 8,143,025 - Wu , et al. March 27, 2	2012-03-27
Antibodies Against Vascular Endothelial Growth Factor Receptor-1 App 20110269186 - WU; Yan ; et al.	2011-11-03
Antibodies Against Vascular Endothelial Growth Factor Receptor-1 App 20100028347 - Wu; Yan ; et al.	2010-02-04
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability App 20090060909 - LIAO; Fang ; et al.	2009-03-05
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability App 20080317750 - LIAO; Fang ; et al.	2008-12-25
Antibody Antagonists Of Ve-cadherin Without Adverse Effects On Vascular Permeability App 20080311121 - Liao; Fang ; et al.	2008-12-18
Antibody antagonists of VE-cadherin without adverse effects on vascular permeability Grant 7,371,574 - Liao , et al. May 13, 2	2008-05-13
Method of treating atherosclerosis and other inflammatory diseases App 20040247597 - Carmeliet, Peter ; et al.	2004-12-09
Method and composition for inhibiting heparanase activity App 20040247577 - Bohlen, Peter ; et al.	2004-12-09
Tri-hybrid melanoma antigen App 20040132972 - Kang, Xiaoqiang ; et al.	2004-07-08
Antibody antagonists of VE-cadherin without adverse effects on vascular permeability App 20020160003 - Liao, Fang ; et al.	2002-10-31

Company Registrations

SEC

0001260929

HICKLIN DANIEL J

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.